Skip to contentP
Palisade Bio, Inc.
P
PALIPalisade Bio, Inc. Released May 9, 2012, after the close
10-Q filed May 9, 2012, 39 days after period end · 0001144204-12-027147
Q1 2012 · 10-Q
Revenue$156.25K$156.25Kno prior Q1 2011 on fileno prior Q4 2011 on file Net Income-$2.45M-$2.45M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
N/M vs Q4 2011
EPS Diluted-$0.05-$0.05N/M vs Q1 2011no prior Q4 2011 on file Operating Income-$2,463,216N/M Operating Cash Flow-$2,100,610N/M Free Cash Flowderived-$2,100,610N/M Margins · derivedOperating margin-1576.5%
Net margin-1569.8%
ended Mar 31, 2012 · filed May 9, 2012 · 39 d after period end